In today’s recent session, 0.49 million shares of the DarioHealth Corp (NASDAQ:DRIO) have been traded, and its beta is 1.47. Most recently the company’s share price was $0.66, and it changed around -$0.07 or -8.61% from the last close, which brings the market valuation of the company to $27.57M. DRIO at last check was trading at a discount to its 52-week high of $1.93, offering almost -192.42% off that amount. The share price’s 52-week low was $0.50, which indicates that the recent value has risen by an impressive 24.24% since then. We note from DarioHealth Corp’s average daily trading volume that its 10-day average is 0.28 million shares, with the 3-month average coming to 683.37K.
DarioHealth Corp stock received a consensus recommendation rating of Buy, based on a mean score of 1.67. If we narrow it down even further, the data shows that 0 out of 3 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 1 recommended DRIO as a Hold, whereas 2 deemed it a Buy, and 0 rated it as Underweight. DarioHealth Corp is expected to report earnings per share of -0.05 for the current quarter.
DarioHealth Corp (NASDAQ:DRIO) trade information
Instantly DRIO has been showing red trend so far today with a performance of -8.61% on intraday trading today. The performance over the last five days has remained in the green territory. The rise to weekly highs of 0.7549 on recent trading dayincreased the stock’s daily price by 12.57%. The company’s shares are currently down -15.65% year-to-date, but still up 14.80% over the last five days. On the other hand, DarioHealth Corp (NASDAQ:DRIO) is -0.41% down in the 30-day period. We can see from the shorts that 2.7 million shares have been sold at a short interest cover period of 10.0 day(s).
The consensus price target as assigned by Wall Street analysts is $10.75, which translates to bulls needing to increase their stock price by 93.86% from its current value. Analyst projections state that DRIO is forecast to be at a low of $7.5 and a high of $14.
DarioHealth Corp (DRIO) estimates and forecasts
The year-over-year growth rate is expected to be 20.01%, up from the previous year.
Consensus estimates provided by 3 financial analysts predict the company will bring in an average of 7.47M in revenue for the current quarter. 3 analysts expect DarioHealth Corp to make 7.76M in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 5.76M and 6.25M respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 29.81%. Forecasts for the next quarter put sales growth at 24.09%.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 41.84%. DarioHealth Corp earnings are expected to increase by 57.38% in 2025, but the outlook is positive 56.56% per year for the next five years.
DRIO Dividends
DarioHealth Corp’s next quarterly earnings report is expected to be released on 2025-Mar-09.
DarioHealth Corp (NASDAQ:DRIO)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 21.28% of DarioHealth Corp shares, and 20.20% of them are in the hands of institutional investors. The stock currently has a share float of 25.66%. DarioHealth Corp stock is held by 45.0 institutions, with NANTAHALA CAPITAL MANAGEMENT, LLC being the largest institutional investor. By 2024-06-30, it held 6.9429% of the shares, which is about 2.39 million shares worth $2.85 million.
APPIAN WAY ASSET MANAGEMENT LP, with 3.9947% or 1.38 million shares worth $1.64 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Extended Market Index Fund were the top two Mutual Funds as of Dec 31, 2024 . The former held 355.61 shares worth $0.24 million, making up 0.86% of all outstanding shares. On the other hand, Fidelity Concord Street Trust-Fidelity Extended Market Index Fund held roughly 146.08 shares worth around $96892.0, which represents about 0.35% of the total shares outstanding.
